Хайлтын үр дүнгүүд - David R. Macdonald
- 21-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
-
3
Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy -н Olivier Chinot, David R. Macdonald, Lauren E. Abrey, Gudrun Zahlmann, Yannick Kerloëguen, Timothy F. Cloughesy
Хэвлэсэн 2013Revisão -
4
-
5
-
6
-
7
Canadian Recommendations for the Treatment of Recurrent or Progressive Glioblastoma Multiforme -н Jacob C. Easaw, Warren Mason, James Perry, Normand Laperrière, David D. Eisenstat, Rolando F. Del Maestro, K. Bélanger, Dorcas Fulton, David R. Macdonald
Хэвлэсэн 2011Artigo -
8
Survey of treatment recommendations for anaplastic oligodendroglioma -н Lauren E. Abrey, David N. Louis, Nina A. Paleologos, Andrew B. Lassman, Jeffrey J. Raizer, Warren Mason, Jonathan L. Finlay, David R. Macdonald, Lisa M. DeAngelis, J. Gregory Cairncross
Хэвлэсэн 2007Artigo -
9
Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas -н J. Gregory Cairncross, Keisuke Ueki, Magdelena C. Zlatescu, David K. Lisle, Dianne M. Finkelstein, Robert Hammond, Jonathan S. Silver, Paul C. Stark, David R. Macdonald, Yasushi Ino, David A. Ramsay, David N. Louis
Хэвлэсэн 1998Artigo -
10
Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131 -н Michael A. Vogelbaum, Brian Berkey, David M. Peereboom, David R. Macdonald, Caterina Giannini, John H. Suh, Robert B. Jenkins, James G. Herman, Paul D. Brown, Deborah T. Blumenthal, Christopher Biggs, Christopher J. Schultz, Minesh P. Mehta
Хэвлэсэн 2008Artigo -
11
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma -н Michael Weller, Thierry Gorlia, J. G. Cairncross, Martin J. van den Bent, Warren Mason, K. Bélanger, Alba A. Brandes, Ulrich Bogdahn, David R. Macdonald, Peter Forsyth, Andrea O. Rossetti, Denis Lacombe, R.O. Mirimanoff, Charles J. Vecht, Roger Stupp
Хэвлэсэн 2011Artigo -
12
Phase II study of PX-866 in recurrent glioblastoma -н Marshall Pitz, Elizabeth A. Eisenhauer, Mary MacNeil, Brian Thiessen, Jacob C. Easaw, David R. Macdonald, David D. Eisenstat, Ankineedu Saranya Kakumanu, Muhammad Salim, Haji Chalchal, Jeremy A. Squire, Ming‐Sound Tsao, Suzanne Kamel‐Reid, Shantanu Banerji, Dongsheng Tu, Jean Powers, Diana F. Hausman, Warren Mason
Хэвлэсэн 2015Artigo -
13
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Ef... -н Timothy F. Cloughesy, Gaetano Finocchiaro, Cristóbal Belda-Iniesta, Lawrence D. Recht, Alba A. Brandes, Estela Pineda, Tom Mikkelsen, Olivier Chinot, Carmen Balañá, David R. Macdonald, Manfred Westphal, Kirsten Hopkins, Michael Weller, Carlos Bais, Thomas Sandmann, Jean-Marie Bruey, Hartmut Koeppen, Bo Liu, Wendy Verret, S. Phan, David S. Shames
Хэвлэсэн 2017Artigo -
14
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group -н Nils D. Arvold, Terri S. Armstrong, Katherine E. Warren, Susan M. Chang, Lisa M. DeAngelis, Jaishri O. Blakeley, Marc C. Chamberlain, Erin Dunbar, Herbert H. Loong, David R. Macdonald, David A. Reardon, Michael A. Vogelbaum, Ying Yuan, Michael Weller, Martin J. van den Bent, Patrick Y. Wen
Хэвлэсэн 2018Revisão -
15
Clinical trial end points for high-grade glioma: the evolving landscape -н D. A. Reardon, E. Galanis, John DeGroot, Timothy F. Cloughesy, Jeffrey S. Wefel, Kathleen R. Lamborn, A. B. Lassman, Mark R. Gilbert, John H. Sampson, Wolfgang Wick, Marc C. Chamberlain, David R. Macdonald, Minesh P. Mehta, Michael A. Vogelbaum, Shannon Chang, Martin J. van den Bent, Patrick Y. Wen
Хэвлэсэн 2011Revisão -
16
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group -н Patrick Y. Wen, David R. Macdonald, David A. Reardon, Timothy F. Cloughesy, A. Gregory Sorensen, Evanthia Galanis, John DeGroot, Wolfgang Wick, Mark R. Gilbert, Andrew B. Lassman, Christina Tsien, Tom Mikkelsen, Eric T. Wong, Marc C. Chamberlain, Roger Stupp, Kathleen R. Lamborn, Michael A. Vogelbaum, Martin J. van den Bent, Susan M. Chang
Хэвлэсэн 2010Artigo -
17
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors -н Andrew B. Lassman, Khê Hoang‐Xuan, Mei‐Yin C. Polley, Alba A. Brandes, J. Gregory Cairncross, Johan M. Kros, Lynn S. Ashby, Martin Taphoorn, Luís Souhami, Winand N.M. Dinjens, Nadia N. Laack, Mathilde C.M. Kouwenhoven, Karen Fink, Pim J. French, David R. Macdonald, Denis Lacombe, Minhee Won, Thierry Gorlia, Minesh P. Mehta, Martin J. van den Bent
Хэвлэсэн 2022Artigo -
18
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria -н Lakshmi Nayak, Lisa M. DeAngelis, Alba A. Brandes, David M. Peereboom, Evanthia Galanis, Nancy U. Lin, Riccardo Soffietti, David R. Macdonald, Marc C. Chamberlain, James Perry, Kurt A. Jaeckle, Minesh P. Mehta, Roger Stupp, Alona Muzikansky, Elena Pentsova, Timothy F. Cloughesy, Fábio M. Iwamoto, J. C. Tonn, Michael A. Vogelbaum, Patrick Y. Wen, Martin J. van den Bent, David A. Reardon
Хэвлэсэн 2017Revisão -
19
Association of<i>MGMT</i>Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide -н Erica H. Bell, Peixin Zhang, Barbara J. Fisher, David R. Macdonald, Joseph P. McElroy, Glenn J. Lesser, Jessica L. Fleming, Arup Chakraborty, Ziyan Liu, Aline Paixão Becker, Denise Fabian, Kenneth Aldape, Lynn S. Ashby, Maria Werner‐Wasik, Eleanor Walker, Jean-Paul Bahary, Young Kwok, Ya-Yu Tsai, Nadia N. Laack, Christopher J. Schultz, Heidi J. Gray, H. Ian Robins, Minesh P. Mehta, Arnab Chakravarti
Хэвлэсэн 2018Artigo -
20
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults -н Patrick Y. Wen, Martin J. van den Bent, Gilbert Youssef, Timothy F. Cloughesy, Benjamin M. Ellingson, Michael Weller, Evanthia Galanis, Daniel P. Barboriak, John de Groot, Mark R. Gilbert, Raymond Y. Huang, Andrew B. Lassman, Minesh P. Mehta, Annette M. Molinaro, Matthias Preusser, Rifaquat Rahman, Lalitha Shankar, Roger Stupp, Javier Villanueva-Meyer, Wolfgang Wick, David R. Macdonald, David A. Reardon, Michael A. Vogelbaum, Susan M. Chang
Хэвлэсэн 2023Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Oncology
Cancer research
Clinical trial
Glioma
Chemotherapy
Radiation therapy
Glioblastoma
Pathology
Temozolomide
Cancer
Astrocytoma
Clinical endpoint
Cyclophosphamide
Lomustine
Medical physics
Oligodendroglioma
Phases of clinical research
Vincristine
Brain tumor
Magnetic resonance imaging
Mathematics
Nuclear medicine
Radiology
Alternative medicine
Bevacizumab
Biochemistry
Biology
Chemistry